Identifying biomarkers of stress induced neurophysiological changes and emotion...
Identifying biomarkers of stress induced neurophysiological changes and emotion regulation deficits to predict relapse during nicotine abstinence
Tobacco smoking is the primary preventable cause of death and disability worldwide. Although there are numerous pharmacotherapies and psychological interventions to assist with smoking cessation, most users relapse following absti...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2019-111594RB-I00
CAMBIOS METABOLOMICOS INDUCIDOS POR LA RECAIDA EN EL CONSUMO...
97K€
Cerrado
SAF2014-59648-P
MECANISMOS NEUROBIOLOGICOS IMPLICADOS EN LA PERDIDA DE CONTR...
472K€
Cerrado
BETTERCHOICES
Understanding and improving choices: investigating the role...
217K€
Cerrado
RTI2018-101837-B-I00
SUSTRATOS PSICONEUROENDOCRINOS Y AMBIENTALES EN EL TRASTORNO...
74K€
Cerrado
PSI2016-80082-P
AJUSTE TEMPORAL, ENCADENAMIENTO Y EFECTOS DE LOS CANNNABINOI...
71K€
Cerrado
PSI2016-79368-R
ESTUDIO LONGITUDINAL DE UNA NUEVA BATERIA NEUROPSICOLOGICA P...
28K€
Cerrado
Información proyecto BioNic
Duración del proyecto: 48 meses
Fecha Inicio: 2021-04-15
Fecha Fin: 2025-05-01
Líder del proyecto
UNIVERSITY OF CYPRUS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
146K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Tobacco smoking is the primary preventable cause of death and disability worldwide. Although there are numerous pharmacotherapies and psychological interventions to assist with smoking cessation, most users relapse following abstinence, while only ~15% of abstinent individuals achieve long-term abstinence of more than 6-12 months. Therefore, there is a need to identify smokers at higher risk for relapse, to facilitate the development of personalized pharmacotherapies for the treatment of nicotine addiction. In this context, BioNic proposes an interdisciplinary approach to examine the unique and/or interactive effects of trait-like vulnerability factors (baseline emotion regulation ability) and biomarkers of state responses to stress (emotion regulation and synchronized neural activation response to stress) prior to smoking cessation, on cravings, abstinence adherence, and response to an established smoking cessation intervention. During this fellowship, the in-depth expertise of the researcher in studying mechanisms underlying relapse to abuse drugs following abstinence using preclinical models, combined with the expertise on human psycho- and neuro-physiological measurements that he will acquire at the Host lab will provide data and publications that will contribute to the identification of biomarkers predicting nicotine relapse vulnerability prior to smoking cessation. This work will unveil a new critical link between emotion regulation deficits and neural activation changes that together will predict maintenance of smoking abstinence. Overall, this fellowship will strengthen the academic profile of the Researcher and will act as a leverage towards securing future research funding and securing a tenure track position in Europe.